Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
VANCOUVER, Canada, May 11, 2026 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) ("Oroco" or the "Company") is pleased to announce the appointment of Charles Cryer as Chief Executive Officer and as a Director of the Company, effective June 16, 2026.
NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
BsStrategy Logo NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- Cryptocurrency markets continue to operate at a pace that can be difficult for individual users to follow manually. Price movement across Bitcoin, Ethereum, Dogecoin, and other digital assets can change quickly as global liquidity, market sentiment, on-chain activity, and macroeconomic news develop throughout the day.
NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.
NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Trip.com Group Limited (NASDAQ: TCOM) and certain of its officers.
ZUG, Switzerland, May 10, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced a positive outcome of its final pre-BLA meeting held on April 1, 2026, with the FDA on the HS program of its Nanobody® SLK.
RSS
